TheEdgeResearch
Home / Stocks / LTTSF

Lotus Ventures Inc. (LTTSF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.01 ▼ -68.71%
Market Cap
$458,846
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.32
52-Wk Range
0.0041-0.0525
CEO
Dale Bernard McClanaghan MBA
Country
CA
Currency
USD

Lotus Ventures Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.01, down 68.71% on the session, giving a market capitalisation of $458,846. On trailing twelve-month figures it carries a trailing P/E of -0.48, a net margin of -93.7%. Its beta of -0.32 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.48
Price / Sales
0.45
Price / Book
0.10
EV / EBITDA
-3.32
Gross margin
-6.9%
Operating margin
-79.6%
Net margin
-93.7%
Return on equity
Debt / equity
0.27
Current ratio
0.36
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2018-09-11
Headquarters
Vancouver, BC, CA
About Lotus Ventures Inc.

Headquartered in Vancouver, Canada, Lotus Ventures Inc. was established in 2007. The company is actively engaged in the Canadian market, focusing on the growth, processing, and distribution of cannabis products specifically for medical applications. Its range of offerings is commercially available under the Lotus Cannabis Co. brand.

Comparable companies

Lotus Ventures Inc. is most often compared with the following Healthcare names:

AGFAFALSEELVAYFLURFLAXAFMSITFPLSISBUDFSLGWFVEGGD
More research on LTTSF
LTTSF technical analysis LTTSF TheEdge Score Compare against peers
Open full interactive analysis & DCF →